UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Regulators and receptors of the complement system

Authors
M Kathryn Liszewski, PhD
John P Atkinson, MD
Section Editors
E Richard Stiehm, MD
Peter H Schur, MD
Deputy Editor
Anna M Feldweg, MD

INTRODUCTION

Precise control of the complement system is necessary because of its potent proinflammatory and cellular destructive capabilities. The regulation of the complement system will be reviewed here. In order to fully comprehend the functions of the various regulatory proteins, it is helpful to be familiar with the complement pathways, which are reviewed elsewhere. (See "Complement pathways".)

COMPLEMENT REGULATION

Nearly one-half of all complement proteins serve a regulatory function [1-4]. The goal of regulation is to prevent complement damage to normal host tissue (inappropriate or wrong target) and fluid-phase activation (no target) [5]. Deficiencies of control proteins lead to excessive complement activation and significant morbidity and mortality. (See "Inherited disorders of the complement system".)

Regulatory proteins inhibit the system by destabilizing activation complexes and by mediating specific proteolysis of activation-derived fragments. The complement pathways are regulated at the following critical steps:

Activation (initiation)

Amplification (convertase formation)

               
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Dec 13, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009; 9:729.
  2. Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res 2010; 20:34.
  3. Lesher AM, Song WC. Review: Complement and its regulatory proteins in kidney diseases. Nephrology (Carlton) 2010; 15:663.
  4. Bajic G, Degn SE, Thiel S, Andersen GR. Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J 2015; 34:2735.
  5. Sjöberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol 2009; 30:83.
  6. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010; 11:785.
  7. Gaboriaud C, Ling WL, Thielens NM, et al. Deciphering the fine details of c1 assembly and activation mechanisms: "mission impossible"? Front Immunol 2014; 5:565.
  8. Liu D, Lu F, Qin G, et al. C1 inhibitor-mediated protection from sepsis. J Immunol 2007; 179:3966.
  9. Igonin AA, Protsenko DN, Galstyan GM, et al. C1-esterase inhibitor infusion increases survival rates for patients with sepsis*. Crit Care Med 2012; 40:770.
  10. Singer M, Jones AM. Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses. Crit Care 2011; 15:203.
  11. Kim DD, Song WC. Membrane complement regulatory proteins. Clin Immunol 2006; 118:127.
  12. Liszewski MK, Atkinson JP. Complement regulators in human disease: lessons from modern genetics. J Intern Med 2015; 277:294.
  13. Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol 2014; 32:433.
  14. Zeng Z, Surewaard BG, Wong CH, et al. CRIg Functions as a Macrophage Pattern Recognition Receptor to Directly Bind and Capture Blood-Borne Gram-Positive Bacteria. Cell Host Microbe 2016; 20:99.
  15. Irvine KM, Banh X, Gadd VL, et al. CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites. JCI Insight 2016; 1:e86914.
  16. Escudero-Esparza A, Kalchishkova N, Kurbasic E, et al. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly. FASEB J 2013; 27:5083.
  17. Gullstrand B, Mårtensson U, Sturfelt G, et al. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol 2009; 156:303.
  18. Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol 2008; 6:132.
  19. Liszewski MK, Atkinson JP. Complement regulator CD46: genetic variants and disease associations. Hum Genomics 2015; 9:7.
  20. Ozen A, Comrie WA, Ardy RC, et al. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med 2017; 377:52.
  21. Kondos SC, Hatfaludi T, Voskoboinik I, et al. The structure and function of mammalian membrane-attack complex/perforin-like proteins. Tissue Antigens 2010; 76:341.
  22. Serna M, Giles JL, Morgan BP, Bubeck D. Structural basis of complement membrane attack complex formation. Nat Commun 2016; 7:10587.
  23. Haas PJ, van Strijp J. Anaphylatoxins: their role in bacterial infection and inflammation. Immunol Res 2007; 37:161.
  24. Matthews KW, Mueller-Ortiz SL, Wetsel RA. Carboxypeptidase N: a pleiotropic regulator of inflammation. Mol Immunol 2004; 40:785.
  25. Klos A, Tenner AJ, Johswich KO, et al. The role of the anaphylatoxins in health and disease. Mol Immunol 2009; 46:2753.
  26. Kemper C, Köhl J. Novel roles for complement receptors in T cell regulation and beyond. Mol Immunol 2013; 56:181.
  27. Khera R, Das N. Complement Receptor 1: disease associations and therapeutic implications. Mol Immunol 2009; 46:761.
  28. Stoute JA. Complement receptor 1 and malaria. Cell Microbiol 2011; 13:1441.
  29. Zhu XC, Yu JT, Jiang T, et al. CR1 in Alzheimer's disease. Mol Neurobiol 2015; 51:753.
  30. Fonseca MI, Chu S, Pierce AL, et al. Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function. PLoS One 2016; 11:e0149792.
  31. Arakelyan A, Zakharyan R, Khoyetsyan A, et al. Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia. BMC Clin Pathol 2011; 11:10.
  32. Erdei A, Füst G, Gergely J. The role of C3 in the immune response. Immunol Today 1991; 12:332.
  33. Wentink MW, Lambeck AJ, van Zelm MC, et al. CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalities. Clin Immunol 2015; 161:120.
  34. Thiel J, Kimmig L, Salzer U, et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012; 129:801.
  35. Sarma JV, Ward PA. New developments in C5a receptor signaling. Cell Health Cytoskelet 2012; 4:73.
  36. Kemper C. Targeting the Dark Horse of complement: the first generation of functionally selective C5aR2 ligands. Immunol Cell Biol 2016; 94:717.
  37. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4:133.
  38. Riedemann NC, Guo RF, Neff TA, et al. Increased C5a receptor expression in sepsis. J Clin Invest 2002; 110:101.
  39. Unnewehr H, Rittirsch D, Sarma JV, et al. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol 2013; 190:4215.
  40. Kumar V, Ali SR, Konrad S, et al. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J Clin Invest 2006; 116:512.
  41. Atkinson JP. C5a and Fcgamma receptors: a mutual admiration society. J Clin Invest 2006; 116:304.
  42. Boos L, Campbell IL, Ames R, et al. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J Immunol 2004; 173:4708.
  43. Hasegawa K, Tamari M, Shao C, et al. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. Hum Genet 2004; 115:295.
  44. Laumonnier Y, Wiese AV, Figge J, Karsten C. Regulation and function of anaphylatoxins and their receptors in allergic asthma. Mol Immunol 2017; 84:51.
  45. Ghebrehiwet B, Hosszu KK, Valentino A, et al. Monocyte Expressed Macromolecular C1 and C1q Receptors as Molecular Sensors of Danger: Implications in SLE. Front Immunol 2014; 5:278.
  46. Losse J, Zipfel PF, Józsi M. Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. J Immunol 2010; 184:912.
  47. Kuraya M, Ming Z, Liu X, et al. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 2005; 209:689.